Stressed out scientists–who have seen their funding wither during the last eight years–got a glimpse of optimism on Thursday. Democrats unveiled an $825 billion economic stimulus bill that includes tens of billions of dollars in new funding for basic research, science infrastructure and clean-energy initiatives.
According to a report from Nature:
…the 258-page blueprint released by House appropriators would pump $3 billion into the National Science Foundation (NSF), $2 billion into the National Institutes of Health (NIH), $1.9 billion into the Department of Energy and $1.5 billion into university research facilities. Much of that money would be directed toward science infrastructure like renovating buildings or laboratories, but the NSF and NIH would receive $2 billion and $1.5 billion respectively that could be used to pay for thousands of basic research grants that have already been approved but for which there was previously not enough money.
…Most of the stimulus spending would extend over two years, although the bill includes language indicating that money for peer-reviewed grants must be spent within 120 days, which could limit the money to grant proposals already in the pipeline. Report language accompanying the bill indicates that additional funds will be provided to the NIH in fiscal 2010, suggesting that Democratic leaders see this as more than a one-time infusion of cash.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.